EUVIMEDSkopri EUVIMED
Open access

Clinical evaluation of a real-time PCR assay for diagnosis of Helicobacter pylori infection and antibiotic resistance

Chanjuan Fan, Zhen Li, Lili Zhai, Hui Wang, Xiaolin Zhao, Dongling Xie, Yong Cai, Kun Huang, Qixuan Bai, Haiou Ding, Jianping Cheng

International Journal of Clinical and Experimental Pathology · 2024

DOI: 10.62347/clcl4783 ↗

At a glance

Journal article in International Journal of Clinical and Experimental Pathology, 2024. Written by Chanjuan Fan and 10 co-authors. Institution: Department of Gastroenterology and Oncology, Civil Aviation General Hospital Beijing 100123, China. Cited 5 times so far (Crossref); 35 references. The full text is freely available in PubMed Central.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

OBJECTIVES: Helicobacter pylori (H. pylori) is a globally prevalent bacterium that increases the risk of developing various gastrointestinal diseases, including gastric adenocarcinoma. This study aimed to evaluate the performances of real-time PCR assay in detecting H. pylori infection, as well as clarithromycin and levofloxacin resistance, in both stool and gastric biopsy specimens. METHODS: Stool and gastric biopsy specimens were collected from patients within one to three days post-hospitalization. All patients were analyzed for H. pylori infection and resistance to clarithromycin and levofloxacin using a real-time PCR based molecular assay. RESULTS: 169 patients (83 males) with a mean age of 43.6±13.1 years were included in the study. The prevalence of H. pylori was 89.9% (152/169) in stool and 90.5% (153/169) in gastric biopsy samples. The molecular diagnostics employed in this study exhibited a sensitivity of 99.3% and a specificity of 100%, resulting in a diagnostic accuracy rate of 99.6%. Resistance to clarithromycin was 36.1% (61/169) in stool and 44.4% (75/169) in gastric biopsy samples. The molecular tests for clarithromycin resistance demonstrated a sensitivity of 96.8% and a specificity of 86.8%, with an overall diagnostic accuracy of 90.5%. Furthermore, resistance to levofloxacin was 22.5% (38/169) and 26.6% (45/169) in stool and gastric biopsy samples, respectively. The molecular test demonstrated a sensitivity of 80.9% and a specificity of 94.3%, resulting in a diagnostic accuracy of 90.5%. CONCLUSION: The implementation of real-time PCR-based screening for H. pylori infection and resistance to clarithromycin and levofloxacin in the stool may enhance the success rate of eradication therapy.

Subjects

Author keywords

Helicobacter pyloriantibiotic resistanceclarithromycinlevofloxacinreal-time PCR

Authors and institutions

  • Department of Gastroenterology and Oncology, Civil Aviation General Hospital Beijing 100123, China.

Cite

APA

Fan, C., Li, Z., Zhai, L., Wang, H., Zhao, X., Xie, D., Cai, Y., Huang, K., Bai, Q., Ding, H., & Cheng, J. (2024). Clinical evaluation of a real-time PCR assay for diagnosis of Helicobacter pylori infection and antibiotic resistance. International Journal of Clinical and Experimental Pathology. https://doi.org/10.62347/clcl4783

Vancouver

Fan C, Li Z, Zhai L, Wang H, Zhao X, Xie D, et al. Clinical evaluation of a real-time PCR assay for diagnosis of Helicobacter pylori infection and antibiotic resistance. International Journal of Clinical and Experimental Pathology. 2024. doi:10.62347/clcl4783

BibTeX
@article{Fan2024,
  author = {Fan, Chanjuan and Li, Zhen and Zhai, Lili and Wang, Hui and Zhao, Xiaolin and Xie, Dongling and Cai, Yong and Huang, Kun and Bai, Qixuan and Ding, Haiou and Cheng, Jianping},
  title = {Clinical evaluation of a real-time PCR assay for diagnosis of Helicobacter pylori infection and antibiotic resistance},
  journal = {International Journal of Clinical and Experimental Pathology},
  year = {2024},
  doi = {10.62347/clcl4783}
}
Start for free →